Gilead Sciences : GILD

All Gilead Sciences Articles

734 Articles

Douglas A. McIntyre | Aug 28, 2012 at 6:32 AM EDT

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Apple Inc. (NASDAQ: AAPL) pushes for a ban on eight Samsung phones. (Reuters) Best Buy Co. Inc. (NYSE: BBY) will…

Trey Thoelcke | Aug 27, 2012 at 8:10 AM EDT

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date…

Trey Thoelcke | Aug 10, 2012 at 9:51 AM EDT

Biotech: Dendreon and Regeneron Draw Short Interest

The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short…

Jon C. Ogg | Aug 7, 2012 at 8:39 AM EDT

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday…

Jon C. Ogg | Aug 2, 2012 at 11:47 AM EDT

Gilead Options & New High In Stock Bring Hope For Further Upside

Gilead Sciences Inc. (NASDAQ: GILD) is seeing shares surge today on news that Bristol-Myers Squibb Co. (NYSE: BMY) has run…

Paul Ausick | Jul 26, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

The three major US stock indexes opened higher this morning following European Central Bank president Mario Draghi’s promise to “do…

Jon C. Ogg | Jul 24, 2012 at 1:43 PM EDT

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment…

Jon C. Ogg | Jul 3, 2012 at 7:35 AM EDT

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…

Jon C. Ogg | Apr 18, 2012 at 8:23 AM EDT

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow from…

Jon C. Ogg | Apr 4, 2012 at 1:28 PM EDT

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…

Jon C. Ogg | Feb 25, 2012 at 7:31 AM EST

24/7 Wall St. Top Analyst Calls of the Week (BX, APO, CMA, DELL, DANG, EXM, FSLR, GILD, LVLT, ERIC, MAR, ORCL, SUN, VVUS, WBMD)

Jon OggEach weekend we review the many analyst calls we track during the week. Some turn out to be very…

Paul Ausick | Feb 22, 2012 at 4:07 PM EST

24/7 Wall St. Closing Bell (AAPL, DELL, MOS, GILD, DNDN, BAS, CYH, LOPE, RRC, CETV, CHS, DLTR, GRMN, NG, RRD, TOL, HSTM, FIRE, THLD, NFX, CELL)

US equities markets opened lower this morning following surprisingly weak manufacturing reports from Europe and China. Fitch Ratings’ downgrade of…

Jon C. Ogg | Feb 22, 2012 at 8:05 AM EST

Top Analyst Upgrades & Downgrades (ASX, AAPL, BX, BRCM, CIEN, CMA, DELL, DNDN, DANG, GILD, MDT, MOS, EDU, SPIL, TSM)

Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Advanced…

Paul Ausick | Feb 21, 2012 at 4:05 PM EST

24/7 Wall St. Closing Bell (ORCL, ITRI, CSX, ABB, GILD, BKS, BYD, CCO, CIE, DTG, HL, JAKK, M, MDT, PXD, SKS, WLK, THLD, CORT, GTXI, CHTP, WMT, WFT)

US markets opened higher this morning and traded higher for most of the day. The DJIA briefly rose above 13,000…

Jon C. Ogg | Feb 21, 2012 at 8:28 AM EST

Top Analyst Upgrades & Downgrades (ABB, ABG, BBVA, BGS, CSX, GILD, IMUC, INFY, ITRI, KLAC, LRCX, NEE, NSC, ORCL, WSH)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday…

1 … 42 43 44 45 46 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Biotech: Dendreon and Regeneron Draw Short Interest

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Gilead Options & New High In Stock Bring Hope For Further Upside

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

24/7 Wall St. Top Analyst Calls of the Week (BX, APO, CMA, DELL, DANG, EXM, FSLR, GILD, LVLT, ERIC, MAR, ORCL, SUN, VVUS, WBMD)

24/7 Wall St. Closing Bell (AAPL, DELL, MOS, GILD, DNDN, BAS, CYH, LOPE, RRC, CETV, CHS, DLTR, GRMN, NG, RRD, TOL, HSTM, FIRE, THLD, NFX, CELL)

Top Analyst Upgrades & Downgrades (ASX, AAPL, BX, BRCM, CIEN, CMA, DELL, DNDN, DANG, GILD, MDT, MOS, EDU, SPIL, TSM)

24/7 Wall St. Closing Bell (ORCL, ITRI, CSX, ABB, GILD, BKS, BYD, CCO, CIE, DTG, HL, JAKK, M, MDT, PXD, SKS, WLK, THLD, CORT, GTXI, CHTP, WMT, WFT)

Top Analyst Upgrades & Downgrades (ABB, ABG, BBVA, BGS, CSX, GILD, IMUC, INFY, ITRI, KLAC, LRCX, NEE, NSC, ORCL, WSH)

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Gilead Sciences : GILD

All Gilead Sciences Articles

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Biotech: Dendreon and Regeneron Draw Short Interest

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Gilead Options & New High In Stock Bring Hope For Further Upside

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

24/7 Wall St. Top Analyst Calls of the Week (BX, APO, CMA, DELL, DANG, EXM, FSLR, GILD, LVLT, ERIC, MAR, ORCL, SUN, VVUS, WBMD)

24/7 Wall St. Closing Bell (AAPL, DELL, MOS, GILD, DNDN, BAS, CYH, LOPE, RRC, CETV, CHS, DLTR, GRMN, NG, RRD, TOL, HSTM, FIRE, THLD, NFX, CELL)

Top Analyst Upgrades & Downgrades (ASX, AAPL, BX, BRCM, CIEN, CMA, DELL, DNDN, DANG, GILD, MDT, MOS, EDU, SPIL, TSM)

24/7 Wall St. Closing Bell (ORCL, ITRI, CSX, ABB, GILD, BKS, BYD, CCO, CIE, DTG, HL, JAKK, M, MDT, PXD, SKS, WLK, THLD, CORT, GTXI, CHTP, WMT, WFT)

Top Analyst Upgrades & Downgrades (ABB, ABG, BBVA, BGS, CSX, GILD, IMUC, INFY, ITRI, KLAC, LRCX, NEE, NSC, ORCL, WSH)

Silver and Copper Are Outpacing Gold in 2026 and After Following Industrial Metals These 3 ETFs Show How Smart Money Is Playing the Trend

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check

Featured Reads

At 65, Your HSA Stops Being a Medical Account and Starts Beating Your 401(k)

Lower Your Mortgage Payment Without Refinancing, Without Closing Costs, and Without a Credit Check